LIPO - Lipella Pharmaceuticals Inc Net earnings per share (EPS TTM)

Symbol and logo of brand Lipella Pharmaceuticals Inc (LIPO)

The rolling annual earnings per share of Lipella Pharmaceuticals (LIPO) visualizes the impact of data analysis automation and robotic molecule screening on capital. Business resilience is ensured by a cycle of urological tests independent of economic conditions, while sustainability is maintained through strict control of laboratory emissions. The current -4.13 metric represents a fresh level value, helping investors assess the real strength of Lipella Pharmaceuticals (LIPO) regardless of market panic.

LIPO (Lipella Pharmaceuticals) Net earnings per one share for the last twelve months history from 04/28/2023 to 07/19/2025

Lipella - analytical breakdowns and key metrics (LIPO)

- share price and expert price forecast:
Stock Quotes Lipella Pharmaceuticals|LIPO - Analyst Forecast Prices
- market capitalization statistics:
Market Capitalization Lipella Pharma|LIPO - Value Adjusted for Debt and Cash
- business book valuation details:
Book Value per Share Lipella Pharmaceuticals|LIPO - Total Stockholders' Equity|Market Value to Book Value Ratio lipella.com|LIPO - Aggregate Asset Value
- debt obligations and liquidity statistics:
Debt to Equity Lipella Pharmaceuticals|LIPO - Long-Term Debt to Equity|Short-Term Debt to Capital lipella.com|LIPO - Company Total Debt Obligations|Debt to Book Capitalization Ratio Lipella Pharmaceuticals Inc|LIPO - Long-Term Liabilities|Company Short-Term Debts Lipella Pharmaceuticals|Quick Liquidity lipella.com
- net income and valuation multiples indicators:
LIPO - Company Net Income|Expected Profit Lipella Pharmaceuticals|LIPO - Price to Earnings Ratio|Forward P/E Multiple Lipella Pharmaceuticals Inc|LIPO - PEG Multiple|Enterprise Value to EBITDA Ratio Lipella Pharma|LIPO - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months Lipella Pharmaceuticals|LIPO - Earnings per one share for the last 12 months|Quarterly EPS earnings growth lipella.com|LIPO - Earnings per share increase in current year|Earnings growth forecast for next year Lipella Pharmaceuticals
- revenue and sales proceeds data:
LIPO - Revenue and Sales Volume|Company Projected Revenue Lipella Pharmaceuticals, Inc.|LIPO - Market Capitalization-to-Revenue Ratio|Price-to-Projected Revenue Ratio Lipella Pharma|LIPO - Revenue Growth YoY (Last 12 Months)
Fundamental company analysis:LIPO - Lipella Pharmaceuticals
Mass-produced product of Lipella Pharmaceuticals Inc

For Lipella Pharmaceuticals (LIPO), this indicator serves as a measure of the ability to monetize developments in urology and oncology. The calculation of rolling earnings per share is based on the distribution of total net income across all outstanding shares for the year. Analyzing the rolling earnings per share allows for an assessment of the business's real financial stability, stripped of market noise. A diversified pipeline of drug delivery systems minimizes the risk of profit erasure in the event of a single trial failure. This chart's dynamics determine the efficiency of capital management amid biopharmaceutical expansion.

Key competitors

Haleon - Net earnings per share (EPS TTM)|Kenvue - Earnings per share for the last four quarters|VRNA: Net earnings per share (EPS TTM)|Jyong Biotech Corp - Earnings per share for the trailing year|LGND (Ligand Pharmaceuticals Incorporated) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months amneal.com AMRX|Earnings per share for the last twelve months Perrigo (PRGO)|ALVO (Alvotech SA) - Earnings per share for the trailing year|Earnings per share for the last twelve months Liquidia Technologies LQDA|Net earnings per share for the trailing year Galapagos Genomics|ANIP - Earnings per share for the last twelve months|MNKD - Net earnings per share (EPS TTM)|Amphastar Pharmaceuticals (AMPH) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Pacira BioSciences, Inc.|Net earnings per share for the last 12 months SPRY|TBPH: Earnings per share for the trailing year|Earnings per share for the last twelve months aquestive.com (AQST)|Net earnings per share (EPS TTM) scPharmaceuticals, Inc. (SCPH)|Earnings per share for the last twelve months tectonictx.com TECX|Earnings per share for the trailing year TNXP|SXTC - Earnings per share for the last twelve months|Net earnings per share for the last four quarters eupraxiapharma.com EPRX|BHST: Net earnings per share (EPS TTM)|EXOZ - Net earnings per share for the last four quarters|ORMP (oramed.com) - Net earnings per share (EPS TTM)|enterabio.com (ENTX) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) HYFT|ABVC (ABVC BioPharma Inc) - Earnings per share for the trailing year|Cumberland Pharmaceuticals - Net earnings per share for the last 12 months|quantumbiopharma.com (QNTM) - Net earnings per one share for the last twelve months|FibroGen Inc - Net earnings per share (EPS TTM)|Earnings per share for the trailing year TELO (Telomir Pharmaceuticals Inc)|RANI (Rani Therapeutics Holdings, Inc.) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Synergy CHC Corporation|Earnings per share for the last twelve months Rallybio Corp|Lexaria Bioscience (LEXX) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Pulmatrix, Inc. (PULM)|Net earnings per share for the last four quarters Pheton|Earnings per share for the last twelve months Aptorum Group Limited APM|LYRA - Net earnings per share for the last 12 months|IBO: Net earnings per share for the last 12 months|TNFA - Net earnings per share (EPS TTM)|cbdMD Corp (YCBD) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months PRFX (PainReform Limited)|CYTO (Altamira Therapeutics Ltd.) - Net earnings per share (EPS TTM)|OPTN: Earnings per share for the trailing year|Net earnings per share (EPS TTM) PIRS|PROC (procapsgroup.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Petros Pharmaceuticals, Inc. PTPI|Qilian International Holding - Earnings per share for the last twelve months|SLRN - Earnings per share for the last twelve months|Earnings per one share for the last 12 months TFFP